LocaLisa Catheter Navigation Reduces Fluoroscopy Time and Dosage in Ablation of Atrial Flutter

Introduction: Catheter ablation has become a well‐established therapy for isthmus‐dependent right atrial flutter (AFL). Recently, mapping and ablation of AFL have been performed using sophisticated three‐dimensional mapping systems, such as electroanatomic and noncontact mapping systems. The LocaLis...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular electrophysiology Vol. 14; no. 6; pp. 587 - 590
Main Authors Schneider, Michael A.E., Ndrepepa, Gjin, Dobran, Ildiko, Schreieck, Jürgen, Weber, Stefan, Plewan, Andreas, Deisenhofer, Isabel, Karch, Martin R., Schömig, Albert, Schmitt, Claus
Format Journal Article
LanguageEnglish
Published 350 Main Street , Malden , MA 02148 , USA , and 9600 Garsington Road , Oxford OX4 2DQ , UK Blackwell Science Inc 01.06.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction: Catheter ablation has become a well‐established therapy for isthmus‐dependent right atrial flutter (AFL). Recently, mapping and ablation of AFL have been performed using sophisticated three‐dimensional mapping systems, such as electroanatomic and noncontact mapping systems. The LocaLisa system enables nonfluoroscopic navigation of intracardiac electrode catheters based on impedance changes related to catheter movements in transthoracic current fields. The aim of this randomized prospective study was to compare the efficacy of the LocaLisa system with the conventional mapping/ablation approach for radiofrequency ablation of AFL. Methods and Results: Fifty consecutive patients with AFL (39 men and 11 women; age 65 ± 10 years) were studied. The patients were randomly assigned to undergo radiofrequency ablation guided by a conventional fluoroscopy‐based approach (24 patients) or by the LocaLisa system (26 patients). Ablation success rate and documentation of bidirectional isthmus block were 100% in both groups. Compared with fluoroscopy‐guided approaches, LocaLisa‐guided procedures demonstrated a reduction in total fluoroscopy time from 15.9 ± 10.6 minutes to 7.5 ± 6.5 minutes (P < 0.005). Total fluoroscopy dosage was reduced from 21.0 ± 19.8 to 8.7 ± 9.5 Gycm2 (P < 0.05). Fluoroscopy time required for ablation was significantly shortened in the LocaLisa group (2.6 ± 2.6 min) compared with the conventional approach group (11 ± 10 min, P < 0.0005). In 9 (35%) of 26 patients, the ablation could be performed with a fluoroscopy time ≤1 minute. There were no significant differences with regard to the number of radiofrequency applications, fluoroscopy time needed for diagnostic reasons, total procedure time, or other ablation data. Conclusion: Compared with the conventional approach, the LocaLisa system significantly reduces the fluoroscopy times needed for ablation of typical AFL. (J Cardiovasc Electrophysiol, Vol. 14, pp. 587‐590, June 2003)
Bibliography:ArticleID:JCE03017
istex:1E274BF3682BD9B184411E6D47B3D397032DB6E7
ark:/67375/WNG-5HJTMCCT-3
Manuscript received 16 January 2003; Accepted for publication 18 March 2003.
ISSN:1045-3873
1540-8167
DOI:10.1046/j.1540-8167.2003.03017.x